TABLE 1

Scotopic ERG amplitudes in RPE65-deficient dogs, pretreatment, and at peak responses postintravitreal administration of the 9-cis-RAL-CM-chitosan conjugate

	Pretreatment						Posttreatment
	Dog 1	Dog 2	Dog 3 eye 1	Dog 4 eye 1	Dog 3 eye 2	Dog 4 eye 2	Dog 1	Dog 2	Dog 3 eye 1	Dog 4 eye 1	Dog 3 eye 2	Dog 4 eye 2	Statistical analysis P
3 cd·s·m⁻² a-wave	0	0.5	0	0	0	0	21	4	3.5	0	0	8	0.125^{^a}
3 cd·s·m⁻² b-wave	1.2	1	0	0	0	0	47.5	9.5	19.5	8	5.5	19	0.017^{^b}
10 cd·s·m⁻² a-wave	0	1	0	0	0	0	35	9.5	9	2	6.5	13.5	0.031^{^a}
10 cd·s·m⁻² b-wave	1.8	3.5	1.5	0	2	0	60.5	17.5	22.5	11	12.5	21.5	0.031^{^a}

↵^a Failed a Shapiro-Wilk test for normality, a Wilcoxon Signed Rank test was performed.
↵^b Passed a Shapiro-Wilk test for normality, a one-tailed paired Student t test was performed.